Shattuck Labs Inc (STTK) Stock Analysis
Sector: HEALTHCARE - BIOTECHNOLOGY
Exchange: NASDAQ
Key Metrics
- Price: $4.04
- Market Cap: $270.84M
- EPS: $-0.99
- 52-Week High: $4.89
- 52-Week Low: $0.69
Market Sentiment
Shattuck Labs Inc currently has a Neutral sentiment score of 0.06.
About Shattuck Labs Inc
Shattuck Labs, Inc. is a clinical-stage biotechnology company based in Austin, Texas, focused on advancing innovative therapies for cancer and autoimmune diseases. Leveraging its proprietary technology platforms, the company is dedicated to developing targeted treatments aimed at addressing significant unmet medical needs. With a strong commitment to research and development, Shattuck Labs is positioned to make impactful contributions to the biopharmaceutical industry, aiming to improve patie...
GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Shattuck Labs Inc and 4,500+ other companies. Learn more about GNG Pro.
Frequently Asked Questions
Does STTK pay dividends?
Shattuck Labs Inc (STTK) does not currently pay a regular dividend.
What is STTK's market cap?
Shattuck Labs Inc (STTK) has a market capitalization of $270.84M with a current stock price of $4.04.